Confounding Factors in the Detection of Intracranial Hemorrhage With the Infrascanner
Primary Purpose
Ischemic Stroke, Brain Tumor, Brain Surgery
Status
Completed
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
Infrascanner
Sponsored by
About this trial
This is an interventional diagnostic trial for Ischemic Stroke focused on measuring Infrascanner, Intracranial hemorrhage
Eligibility Criteria
Inclusion Criteria:
- Patients with ischemic stroke diagnosed by clinical examination and CT-scan
- Patients with a brain tumor diagnosed by clinical examination and CT-scan or MRI
- Patients with an intracranial hemorrhage diagnosed by clinical examination and CT-scan
- Patients that have undergone brain surgery
- Patients with a normal CT-scan of the brain after head trauma
- Patients with headache complaints and a normal CT-scan of the brain as part of their diagnostic work-up
Exclusion Criteria:
- none
Sites / Locations
- Ziekenhuis Oost-Limburg
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Arm 6
Arm Type
Experimental
Experimental
Experimental
Active Comparator
Experimental
Experimental
Arm Label
Ischemic stroke
Brain tumor
Brain surgery
Intracranial hemorrhage
Headache
Headtrauma
Arm Description
patients suffering from ischemic stroke diagnosed by clinical examination and CT-scan
patients diagnosed with a brain tumor diagnosed by clinical examination and CT-scan or MRI
patients that have undergone brain surgery
patients with intracranial hemorrhage diagnosed by clinical examination and CT-scan
patients with headache complaints and a normal CT-scan of the brain
patients with head trauma and a normal CT-scan of the brain
Outcomes
Primary Outcome Measures
Presence of intracranial hemorrhage as indicated by the Infrascanner compared to the result of the CT-scan (gold standard)
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02809651
Brief Title
Confounding Factors in the Detection of Intracranial Hemorrhage With the Infrascanner
Official Title
A Prospective Study to Determine Confounding Factors in the Detection of Intracranial Hemorrhage With the Infrascanner
Study Type
Interventional
2. Study Status
Record Verification Date
March 2017
Overall Recruitment Status
Completed
Study Start Date
August 2016 (undefined)
Primary Completion Date
February 2017 (Actual)
Study Completion Date
February 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ziekenhuis Oost-Limburg
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The investigators prospectively want to use the Infrascanner in patients with ischemic stroke, patients with brain surgery, patients with brain tumors, patients with intracranial hemorrhage and patients with a normal CT scan of the brain as part of a diagnostic work-up after head trauma or headache to determine to positive and negative predictive value of the Infrascanner in these different settings.
Detailed Description
Infrascanner is a portable device initially designed to detect intracranial hemorrhage in battlefield traumas. Infrascanner uses near infrared spectroscopy to measure cerebral blood flow non-invasively. This is achieved by putting the device against the scalp in 4 different areas (frontal, temporal, parietal, occipital) on the left and right side and by comparing both sides.This allows for the detection of intracranial hemorrhages with a volume upwards of 3.5ml and to a depth of 2.5cm. However, little is known about the influence of other intracranial conditions that could confound the measurements of the Infrascanner (e.g. ischemic stroke, brain surgery, brain tumors,...).
Therefore, the investigators prospectively want to use the Infrascanner in patients with ischemic stroke, patients with brain surgery, patients with brain tumors, patients with intracranial hemorrhage and patients with a normal CT scan of the brain as part of a diagnostic work-up after head trauma or headache to determine the positive and negative predictive value of the Infrascanner in these different settings.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ischemic Stroke, Brain Tumor, Brain Surgery, Intracranial Hemorrhage, Headache, Head Trauma
Keywords
Infrascanner, Intracranial hemorrhage
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderOutcomes Assessor
Allocation
Non-Randomized
Enrollment
89 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Ischemic stroke
Arm Type
Experimental
Arm Description
patients suffering from ischemic stroke diagnosed by clinical examination and CT-scan
Arm Title
Brain tumor
Arm Type
Experimental
Arm Description
patients diagnosed with a brain tumor diagnosed by clinical examination and CT-scan or MRI
Arm Title
Brain surgery
Arm Type
Experimental
Arm Description
patients that have undergone brain surgery
Arm Title
Intracranial hemorrhage
Arm Type
Active Comparator
Arm Description
patients with intracranial hemorrhage diagnosed by clinical examination and CT-scan
Arm Title
Headache
Arm Type
Experimental
Arm Description
patients with headache complaints and a normal CT-scan of the brain
Arm Title
Headtrauma
Arm Type
Experimental
Arm Description
patients with head trauma and a normal CT-scan of the brain
Intervention Type
Device
Intervention Name(s)
Infrascanner
Intervention Description
bilateral measurement cerebral blood flow with near infrared spectroscopy using the Infrascanner on the frontal, temporal, parietal and occipital region of the head.
Primary Outcome Measure Information:
Title
Presence of intracranial hemorrhage as indicated by the Infrascanner compared to the result of the CT-scan (gold standard)
Time Frame
5 minutes
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with ischemic stroke diagnosed by clinical examination and CT-scan
Patients with a brain tumor diagnosed by clinical examination and CT-scan or MRI
Patients with an intracranial hemorrhage diagnosed by clinical examination and CT-scan
Patients that have undergone brain surgery
Patients with a normal CT-scan of the brain after head trauma
Patients with headache complaints and a normal CT-scan of the brain as part of their diagnostic work-up
Exclusion Criteria:
none
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pascal Vanelderen, MD, PhD
Organizational Affiliation
member of Staff
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ziekenhuis Oost-Limburg
City
Genk
State/Province
Limburg
ZIP/Postal Code
3600
Country
Belgium
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Confounding Factors in the Detection of Intracranial Hemorrhage With the Infrascanner
We'll reach out to this number within 24 hrs